N
ALIM

Natixis’s Alimera Sciences ALIM Stock Holding History

Natixis’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,100
Closed -$89K – 437
2014
Q3 		$89K Buy
+1,100
New +$94K ﹤0.01% 402

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Natixis's ALIM Position: Q4 2014 in Review

Natixis sold out of Alimera Sciences (ALIM) in Q4 2014, closing a stake of 1,100 shares — an estimated $89K sold.

Natixis first reported a position in ALIM in Q3 2014 and held it in 1 quarter. The position peaked at $89K in Q3 2014. 67 funds tracked by Wall St. Rank hold ALIM as of Q4 2014.

  • Natixis reported no remaining Alimera Sciences position as of Q4 2014 after selling out during the quarter.
  • Natixis sold 1,100 Alimera Sciences shares in Q4 2014, an estimated $89K.
  • Natixis first reported a position in Alimera Sciences in Q3 2014 and held it in 1 quarter.
  • Natixis's Alimera Sciences position peaked at $89K in Q3 2014.
  • 67 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2014.

Based on Natixis's 13F filing for Q4 2014, filed 17 Feb 2015.